Davian Koren is a Fillmore County home school student, one of 15 area students participating in the Journal Writing Project, now in its 26th year.
As BMI is increasingly recognized as an imperfect way to measure health, UVA researchers share other metrics they rely upon.
Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...
Objective To investigate the correlation between caregivers’ health-related behaviours and the prevalence of ...
According to Trace One, when factoring in eating habits, food insecurity rates, alcohol consumption, and the prevalence of ...
Novo Nordisk (NYSE:NVO) shares are rallying 6.87% to $86.67 as of 10:27 AM ET Friday, after the company reported promising trial results for its new obesity drug, amycretin. Warning! GuruFocus has ...
Viking's obesity-drug program is progressing well. Now management is thinking about manufacturing tie-ups. Viking Therapeutics Inc.'s stock jumped 3% Tuesday, after a bullish note from Oppenheimer ...
LONDON – Medical experts proposed a radical overhaul of how obesity is diagnosed, moving away from relying on body mass alone and adding broader measurements such as heart health. The ...
The newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ways they affect the body—both helpful and harmful—beyond reducing ...
The Lancet medical journal’s Diabetes & Endocrinology Commission last week proposed a new definition and method for diagnosing obesity, beyond simply looking at a person’s Body Mass Index (BMI), the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback